Northern Health, 185 Cooper Street, Epping, VIC, 3076, Australia.
Department of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, 3052, Australia.
World J Surg. 2019 Nov;43(11):2762-2769. doi: 10.1007/s00268-019-05104-w.
The Tokyo Guidelines 2018 (TG18) were developed to aid diagnosis and treatment for acute cholecystitis. The benefits of being treated in an acute general surgical unit (AGSU) include earlier diagnosis and treatment. This study aims to define the usefulness of TG18 before and after the introduction of AGSU.
Patients who underwent cholecystectomy at Northern Health were audited retrospectively and assessed for TG18 diagnostic criteria and outcomes between 1 February 2012 and 1 February 2014 (one-year pre- and post-AGSU).
Five hundred and eighty-seven patients underwent emergency cholecystectomy with 203 (34.6%) patients having a suspected diagnosis, and 234 (39.9%) patients with a definitive diagnosis of acute cholecystitis using TG18 diagnostic criteria. After the introduction of AGSU, time from imaging to operation improved from 2.5 to 1.7 days (p = 0.012). There were more operations occurring during in-hours following AGSU implementation (75.8% vs. 62.7%, p < 0.001). Maximum pre-operative CRP of >26.6 mg/L had a higher likelihood of Clavien-Dindo complication grade 3 or 4 (OR 3.86, 95%CI 1.18-12.63, p = 0.027) compared with TG18 definitive diagnosis criteria (OR 1.50, 95%CI 0.46-4.91, p = 0.501). Surprisingly, there was a trend towards higher complications and readmissions for patients operated within 24 h, although this trend was not significant.
Patients with suspected acute cholecystitis should be stratified clinically and with CRP in an AGSU with TG18 adding little value in a busy metropolitan unit.
《2018 年东京指南》(TG18)旨在为急性胆囊炎的诊断和治疗提供帮助。在急性普通外科病房(AGSU)接受治疗的好处包括更早的诊断和治疗。本研究旨在确定在引入 AGSU 前后 TG18 的实用性。
对 Northern Health 接受胆囊切除术的患者进行回顾性审核,并评估 2012 年 2 月 1 日至 2014 年 2 月 1 日(AGSU 前后各一年)期间 TG18 诊断标准和结果。
587 例患者行急诊胆囊切除术,其中 203 例(34.6%)疑似诊断,234 例(39.9%)符合 TG18 诊断标准明确诊断为急性胆囊炎。AGSU 引入后,从影像学检查到手术的时间从 2.5 天缩短至 1.7 天(p=0.012)。AGSU 实施后,在工作时间内进行手术的比例更高(75.8%比 62.7%,p<0.001)。术前 C 反应蛋白(CRP)>26.6mg/L 发生 Clavien-Dindo 并发症 3 级或 4 级的可能性更高(OR 3.86,95%CI 1.18-12.63,p=0.027),而不符合 TG18 明确诊断标准的可能性(OR 1.50,95%CI 0.46-4.91,p=0.501)。令人惊讶的是,尽管这一趋势并不显著,但在 24 小时内进行手术的患者的并发症和再入院率有上升的趋势。
疑似急性胆囊炎患者应在 AGSU 中进行临床和 CRP 分层,在繁忙的大都市单位中,TG18 几乎没有增加价值。